ABSTRACT
Trichomonas vaginalis is responsible for the most prevalent non-viral sexually transmitted disease worldwide, and yet the mechanisms used by this parasite to establish and maintain infection are poorly understood. We previously identified a T. vaginalis homologue (TvMIF) of a human cytokine, human macrophage migration inhibitory factor (huMIF). TvMIF mimics huMIF’s role in increasing cell growth and inhibiting apoptosis in human host cells. To interrogate a role of TvMIF in parasite survival during infection, we asked whether overexpression of TvMIF (TvMIF-OE) confers an advantage to the parasite under nutrient stress conditions by comparing the survival of TvMIF-OE parasites to that of empty vector (EV) parasites. We found that under conditions of serum starvation, overexpression of TvMIF resulted in increased parasite survival. Serum-starved parasites secrete 2.5-fold more intrinsic TvMIF than unstarved parasites, stimulating autocrine and paracrine signaling. Similarly, we observed that addition of recombinant TvMIF increased the survival of the parasites in the absence of serum. Recombinant huMIF likewise increased the parasite survival in the absence of serum, indicating that the parasite may use this host survival factor to resist its own death. Moreover, TvMIF-OE parasites were found to undergo significantly less apoptosis and reactive oxygen species (ROS) generation under conditions of serum starvation, consistent with increased survival being the result of blocking ROS-induced apoptosis. These studies demonstrated that a parasitic MIF enhances survival under adverse conditions and defined TvMIF and huMIF as conserved survival factors that exhibit cross talk in host-pathogen interactions.
KEYWORDS: Trichomonas vaginalis, apoptosis, macrophage migration inhibitory factor, nutrient starvation
IMPORTANCE
Macrophage migration inhibitory factor (MIF) is a conserved protein found in most eukaryotes which has been well characterized in mammals but poorly studied in other eukaryotes. The limited analyses of MIF proteins found in unicellular eukaryotes have focused exclusively on the effect of parasitic MIF on the mammalian host. This was the first study to assess the function of a parasite MIF in parasite biology. We demonstrate that the Trichomonas vaginalis MIF functions to suppress cell death induced by apoptosis, thereby enhancing parasite survival under adverse conditions. Our research reveals a conserved survival mechanism, shared by a parasite and its host, and indicates a role for a conserved protein in mediating cross talk in host-pathogen interactions.
INTRODUCTION
Trichomonas vaginalis, an extracellular unicellular parasite, causes the most common non-viral sexually transmitted infection in the world (1) but has been long neglected. Thus, the mechanisms that drive parasite pathogenesis and the disease epidemiology are poorly understood (2). However, this is changing as more molecular and genetic tools for analyses are developed (3, 4). The majority of T. vaginalis infections are asymptomatic. When they are symptomatic, the manifestations of infection vary greatly and may include inflammation of the urogenital tract, preterm delivery, and increased chances of HIV co-infection (5, 6). The factors that determine how the parasite maintains the infection in the vaginal microenvironment, where the nutrients, hormones, and pH are constantly changing, remain largely unknown (7–9).
Macrophage migration inhibitory factor (MIF) is a highly conserved eukaryotic protein found across unicellular protists, plants, arthropods, and mammals (10–13). Human MIF (huMIF) has been widely studied and is known to play essential roles in cell growth, survival and in cancer growth in humans (14–16). In our previous study, we reported that T. vaginalis shares a homologous protein (TvMIF) with the human host and that TvMIF can activate the same survival pathways as huMIF in human cells (17). MIF homologues found in other eukaryotic parasites are known to modulate the host immune system and to activate huMIF pathways (10, 18–21). Although the effects of parasite-derived MIFs from parasites on host cells have been studied, the role of MIF in parasites and non-mammalian systems is poorly understood.
T. vaginalis and other parasitic protists share certain apoptotic phenotypes with mammalian systems such as DNA fragmentation and phosphatidylserine exposure (22–25). However, no factor that either stimulates or suppresses apoptosis in these divergent, unicellular eukaryotes has yet been identified. In this report, we describe the anti-apoptotic effect caused by TvMIF, a conserved eukaryotic protein, and reveal similarities between this protein and its mammalian homologue. We also provide evidence that T. vaginalis is able to exploit huMIF to enhance its survival during nutrient starvation. These studies uncovered a highly conserved eukaryotic protein used by a parasite and its host to enhance survival.
RESULTS
T. vaginalis MIF (TvMIF) enhances survival of the parasites under conditions of nutrient stress.
We have previously shown that the homologue of huMIF in the parasite T. vaginalis (TvMIF) can induce the growth and activation of anti-apoptotic pathways in human host cells (17). To investigate whether TvMIF can perform a similar function and hence enhance the survival of the parasite under adverse conditions, we have studied the role of TvMIF in parasite survival under conditions of nutrient and density stress. T. vaginalis is typically grown in Diamond’s media supplemented with serum (26). The parasite will not grow in the absence of serum as it provides lipids, precursors of nucleotides, and amino acids required for parasite survival (26, 27). Parasites also cease to swim and die within hours after reaching a density of 5 × 106 cells/ml in Diamond’s media supplemented with serum (27). As a first step toward determining whether TvMIF plays a role in parasite survival, we compared the survival rates of parasites transfected with (28) and overexpressing TvMIF (TvMIF-OE) with those transfected with an empty vector (EV). Immunoblotting confirmed that expression of TvMIF in TvMIF-OE parasites is approximately 17-fold greater than in EV control parasites (see Fig. S1 in the supplemental material).
Fluorescence-activated cell sorter (FACS) analyses of living cells assessed using Zombie Red viability dye to compare TvMIF-OE and EV parasites were conducted using parasites grown in serum-free media or at a high density. We found that TvMIF-OE parasites survived significantly better than EV parasites in serum-free media after 8 h of incubation and that this survival phenotype became more pronounced after 24 to 32 h of starvation (Fig. 1A; see also Fig. S2). Comparison of the survival rates of TvMIF-OE and EV parasites at densities as high as 107 cells/ml or 2 × 107 cells/ml also revealed the death of a significantly higher proportion of EV parasites than of TvMIF-OE parasites at 4 and 8 h after they were subjected to density stress (Fig. 1B). When grown in regular media supplemented with serum, EV and TvMIF-OE had similar growth rates (Fig. S3), demonstrating that TvMIF promotes parasite survival under adverse conditions.
TvMIF is secreted as both a free soluble protein and an exosomal protein.
We have previously demonstrated that T. vaginalis secretes small vesicles called exosomes (29, 30) and that TvMIF is found in the exosomal proteome (31). As the survival pathways activated by huMIF require a secreted soluble form of the protein (16, 32), we examined both the exosomal fractions (Exo) and the non-exosomal soluble fractions (NESF) secreted by the parasite for TvMIF using a Vivaflow crossflow cassette and an ultracentrifugation-based method (Fig. 2A). Parasites grown overnight were collected and then incubated in phosphate-buffered saline (PBS)–5% sucrose at either 16°C (negative control for secretion) or 37°C. After 2 h of incubation, the cells were pelleted and lysed to make whole-cell lysates (Wcl). The supernatant was passed through a Vivaflow crossflow cassette using a 100-kDa molecular weight cutoff (MWCO) to separate the heavier exosomes (Exo > 100 kDa) from the lighter non-exosomal secreted fraction (NESF < 100 kDa). The level of NESF TvMIF was found to be 1.4-fold higher than that of Exo TvMIF by immunoblotting using an anti-TvMIF antibody (4) (Fig. 2B). As the Exo fraction had much less protein than the Wcl fraction and NESF from equal numbers of cells, equal (20 µg) amounts of protein were loaded in each fraction. At 37°C, 20 µg of protein is equal to 2.87% of the total NESF and 17.2% of the Exo fraction. As a result, we can reason that approximately 8.4-fold-more TvMIF is secreted in the NESF than in the Exo (17.2% divided by 2.87% and then multiplied by 1.4-fold). These data show that the majority of total secreted TvMIF is present as a soluble protein.
Both intracellular TvMIF and secreted TvMIF are induced during serum starvation.
As shown in Fig. 1, overexpression of TvMIF increased the survival of the parasites during nutrient stress. Thus, we asked if induction of TvMIF expression and its secretion play a role in the enhanced survival. First, to test if intracellular TvMIF expression is induced under conditions of serum starvation, we collected the whole-cell lysates (Wcl) from cells starved for 16 or 24 h and TvMIF levels were quantified by immunoblotting. Intracellular TvMIF was found to be induced 1.6-fold at 16 h and 2.2-fold at 24 h after starvation (Fig. 3A and B). For determining TvMIF secretion levels under conditions of serum starvation, parasites grown overnight in complete Diamond’s media were collected, resuspended, and incubated in serum-free media for 3 h or 6 h at 37°C. Cells were then spun, resuspended in PBS–5% sucrose, and incubated for an additional 2 h at 37°C. Cells were then pelleted and lysed to make Wcl, and the supernatant was collected to assess secretion. Immunoblot analyses showed that the secreted TvMIF were induced ~2-fold and 2.5-fold higher from cells incubated in serum-free media for 3 and 6 h, respectively, than from parasites grown in serum-containing media (Fig. 3C). Neomycin phosphotransferase (Neo), a non-secreted protein, was used as a control to monitor cell lysis. The presence of Neo signal only in the Wcl confirms that the TvMIF signal detected was the result of secretion and not cell lysis.
Addition of recombinant MIFs increases survival of the parasite during serum starvation.
As survival and anti-apoptotic pathways are activated by huMIF in an autocrine manner (15, 33, 34) and TvMIF secretion is induced during serum starvation (Fig. 3), we generated recombinant MIF and added it to parasites to directly test whether soluble TvMIF plays a role in enhancing parasite survival during serum starvation. As shown in Fig. 4A, 50 ng/ml of recombinant TvMIF (rTvMIF) increased parasite survival 1.2-fold at 4 h and 1.3-fold at 8 h after serum starvation. Human MIF has been reported to be secreted during parasitic infection (35, 36). Thus, we tested whether recombinant huMIF (rhuMIF) can also increase parasite survival. We found that 50 ng/ml of rhuMIF induced parasite survival 1.2-fold at 8 h (Fig. 4B). These results support the idea of ability of the parasite to respond to both TvMIF and huMIF, increasing parasite survival, and indicate that T. vaginalis can hijack huMIF to enhance its survival.
Parasites overexpressing TvMIF can enhance survival of neighboring parasites in co-cultures.
Having established that secreted TvMIF is involved in signaling to parasites, we next tested whether this occurs in an autocrine manner only or can operate in trans. To test if secreted TvMIF can enhance the survival of neighboring parasites, we set up a co-culture of EV and TvMIF-OE parasites in a transwell apparatus using complete Diamond’s media. The bottom wells contained EV, and the top wells, separated from the bottom wells by membranes with 0.4-µm pores, contained either EV or TvMIF-OE. Parasites in both the top and bottom wells were passaged into new media daily for 7, 14, and 21 days (Fig. 5A) to maximize exposure of EV to abundant TvMIF secreted from TvMIF-OE. Then, the cultures were switched to serum-free media to induce nutrient stress and we measured the survival of the EV parasites in the bottom wells under conditions of co-culture with either EV or TvMIF-OE parasites. We found that EV parasites co-cultured with TvMIF-OE parasites for 7 days had a 1.4-fold-higher survival rate than those co-cultured with EV control parasites, that those co-cultured for 14 days had a 1.7-fold-higher survival rate, and that those co-cultured for 21 days had a 2.3-fold-higher survival rate and that the survival advantage became more dramatic with increasing numbers of days of co-culturing (Fig. 5B). These data indicate that the abundance of TvMIF secretion from TvMIF-OE parasites enhanced the survival of neighboring EV parasites, possibly exerting this effect via a positive-feedback loop.
TvMIF inhibits parasite apoptosis.
HuMIF is known to activate anti-apoptotic pathways in human cells (14, 15, 37–39). To test whether TvMIF inhibits the apoptosis of the parasites during serum starvation, we employed a double-staining method similar to the commonly used annexin V and propidium iodide (PI) method (40) except that we replaced PI with Zombie Red as the viability dye to exclude dead cells in the population. Annexin V, which labels externalized phosphatidylserine, is used as an indicator of the number of parasites undergoing apoptosis (40). Using this assay, we observed that EV parasites had slightly more apoptosis than TvMIF-OE parasites at 16 h (P value = 0.07). Moreover, after 24 h of serum starvation, EV parasites were significantly more apoptotic than TvMIF-OE parasites (P value = 0.01) (Fig. 6A). To further validate the apoptotic phenotypes of the serum-starved parasites, we examined the nuclei of EV and TvMIF-OE parasites grown in serum-free media for 16 h, as the nuclei of T. vaginalis are reported to become condensed and fragmented when treated with apoptosis inducers (24, 25). As shown in Fig. 6B and quantified in Fig. 6D, both EV and TvMIF-OE parasites had low levels of DNA fragmentation at 0 h. In contrast, 16 h after serum starvation, ~55% of EV parasites exhibited apoptotic-like DNA fragmentation, whereas only ~38% of TvMIF-OE parasites displayed this phenotype (Fig. 6B to D). These data demonstrate that TvMIF enhancement of parasite survival is associated with a decrease in apoptosis. It is notable that the observed difference between TvMIF-OE and EV parasites with respect to the anti-apoptotic phenotypes seen at 16 and 24 h is not as dramatic as that observed for the survival phenotype (Fig. 1A), indicating that other mechanisms may contribute to survival during serum starvation.
TvMIF inhibits parasite apoptosis during serum starvation via ROS suppression.
Reactive oxygen species (ROS) activate apoptosis signaling in mammalian systems (41), and huMIF is known to inhibit apoptosis by suppressing ROS production (42, 43). To test whether TvMIF-induced survival under conditions of serum starvation is dependent on ROS inhibition, we measured levels of superoxide, a known by-product of ROS signaling, by staining EV and TvMIF-OE parasites with dihydroethidium (DHE). Upon oxidization by superoxide, DHE is converted to fluorescent 2-hydroxyethidium (44) and the intensity can then be used as a measure of ROS levels. We found that TvMIF-OE parasites produced significantly less superoxide than EV parasites when grown without serum for 16 or 24 h (Fig. 7A). To validate the specificity of the DHE signal, we treated EV and TvMIF-OE parasites with the superoxide dismutase (SOD) mimetic manganese(III) tetrakis(1-methyl-4-pyridyl)porphyrin (MnTmPyP) during serum starvation. MnTmPyP significantly decreased the superoxide signal in EV parasites at both 250 µM and 500 µM and in TvMIF-OE parasites at 500 µM (Fig. 7B). The less dramatic effect that MnTmPyP had on TvMIF-OE parasites is consistent with the ability of TvMIF-OE parasites to suppress ROS production prior to the treatment. In addition, the survival of EV parasites was strongly enhanced by MnTmPyP treatment, whereas TvMIF-OE parasite survival was increased only slightly by the addition of 500 µM MnTmPyP (Fig. 7C). The low increase in survival of TvMIF-OE parasites resulted from normalizing the percentages of living cells of treated TvMIF-OE and untreated TvMIF-OE parasites (Fig. 7C) as the untreated TvMIF-OE parasites had higher survival rates than EV. Together, these data indicate that inhibition of superoxide by TvMIF contributes to parasite survival under conditions of serum starvation.
Gene knockout (KO) of TvMIF severely reduced parasite survival in serum-free media.
After completing the work described above, using TvMIF-OE and EV parasites to study the role of TvMIF in parasite survival under nutrient stress, we succeeded in developing CRISPR-Cas9 methods to knock out (KO) genes in T. vaginalis (4). These methods allowed us to KO TvMIF in the parasite (4). As shown in Fig. 8A, immunoblot analyses using the anti-TvMIF antibody confirmed that TvMIF was depleted in the TvMIF KO parasites. To test whether the effects observed in comparisons of wild-type and KO parasites were specific to the loss of TvMIF, we restored TvMIF to the KO parasites (referred to here as "addback parasites") to test whether this rescued the KO phenotype and caused reversion to that of the wild-type parasites. Immunoblot analysis of addback parasites where TvMIF was overexpressed on a plasmid showed that this resulted in greater expression of TvMIF than was observed in the wild-type parasites (Fig. 8A). Testing the wild-type, TvMIF KO, and addback parasites for survival under conditions of serum starvation, we found that TvMIF KO parasites had 16-fold less and 9-fold less survival than the wild-type parasites and 23.7-fold and 27.7-fold less survival than the addback parasites after 16 h and 24 h under conditions of serum starvation, respectively (Fig. 8B). The increase in survival of addback parasites relative to wild-type parasites is consistent with the higher levels of TvMIF expressed in addback parasites, due to the gene’s presence on a multicopy plasmid. To further validate the survival effect of TvMIF, we added rTvMIF to TvMIF KO parasites in serum-free media and found that 100 ng/ml rTvMIF increased the survival 1.7-fold after 24 h, compared to vehicle control (Fig. S4). Together, these results provide definitive evidence that TvMIF plays a crucial role in resistance to death of the parasite under conditions of nutrient stress.
DISCUSSION
We have established a role for TvMIF in the survival of the parasite under adverse conditions. Although MIF has been widely studied in mammals, the function of this conserved protein in other eukaryotes is largely unknown. We demonstrated that overexpression of TvMIF increases parasite survival under conditions of nutrient starvation, which may be important for the parasite to maintain chronic infection in the constantly changing vaginal environment (5). Nutrient starvation was also shown to induce the expression and secretion of TvMIF by the parasite. By co-culturing parasites that overexpress TvMIF (TvMIF-OE) with empty vector (EV) parasites that do not, secreted TvMIF was shown to enhance the survival of EV parasites upon prolonged co-culturing, suggesting the presence of an intracellular positive-feedback pathway by which uptake of TvMIF triggers an increase in TvMIF expression and secretion. We were ultimately able to knock out (KO) TvMIF and to show definitively that the loss of TvMIF severely altered the ability of T. vaginalis to survive under conditions of nutrient stress.
We found that TvMIF inhibits parasite apoptosis during serum starvation, consistent with the increased survival phenotype conferred on TvMIF-OE parasites. These data imply that nutrient deprivation during infection induces parasite apoptotic pathways and that increased production of TvMIF may allow the parasite to survive, awaiting more favorable conditions within the urogenital tract. The ability of huMIF to inhibit apoptosis and to contribute to oncogenesis is well established (15, 38, 45–48). This functional conservation between huMIF and TvMIF is remarkable given their evolutionary divergence. Our findings are consistent with host-parasite interactions providing an environment that allowed co-evolution of the two proteins.
Previous studies indicated that T. vaginalis undergoes apoptosis when treated with drugs known to induce apoptosis in mammalian cells. Treatment with staurosporine (STS) led to DNA condensation and staining with annexin V, both indicators of apoptosis (24). The survival of T. vaginalis under conditions of iron depletion, glucose restriction, or serum starvation has also been described, followed by examination of the resulting differential gene expression (49–51). Re-evaluation of these data revealed that under conditions of glucose restriction, TvMIF mRNA is upregulated by 3.8-fold at 12 h and 1.3-fold at 24 h, indicating that TvMIF may be involved in enhancing parasite survival under conditions of glucose starvation (50). In contrast, RNA analyses of parasites grown under conditions of iron depletion revealed that TvMIF mRNA levels were 2.5 times lower under iron-deficient conditions than under iron-rich conditions (49). However, the time point used to extract RNA for the transcriptome sequencing (RNA-seq) analysis was not stated. Therefore, it is possible that TvMIF was upregulated to exert its survival effect at a different time during the analyses.
Although the studies on RNA regulation under glucose-deficient and iron-deficient conditions (49, 50) provide insights into potential pathways that induce parasite survival, prior to this study, no survival factor had been characterized or manipulated by genetic approaches to directly address mechanisms underlying the survival phenotype. Our study results show that the induction of parasite survival by TvMIF via the inhibition of apoptosis is accompanied by reactive oxygen species (ROS) suppression. These data confirm the evolutionary conservation of apoptosis inhibition pathways, as ROS has been shown to activate apoptosis signaling in mammalian systems (41) and huMIF is known to inhibit apoptosis by suppressing ROS production (42, 43).
Induction of apoptosis in the parasitic protists Leishmania spp., Trypanosoma cruzi, and Trypanosoma brucei is accompanied by an increase in ROS (52–57). However, whether the modulation of apoptosis by MIF has been generally conserved between protists and mammals, as appears to be the case for ROS, is yet to be determined. In this regard, it is notable that the known roles of MIF in Xenopus laevis and Caenorhabditis elegans are not directly related to survival under conditions of stress (58, 59). The main functions of other parasite MIFs have been shown to be focused on their effects on hosts. Leishmania major MIF (LmMIF), Plasmodium species MIF, Toxoplasma gondii MIF, and Entamoeba histolytica MIF can bind huMIF receptor CD74 and modulate host immune responses, activate huMIF pathways such as the extracellular signal-regulated kinase/mitogen-activated protein kinase (ERK/MAPK) pathways, and affect the infection outcome (10, 18, 20, 60, 61). LmMIF and Plasmodium yoelii MIF also inhibit apoptosis of host macrophages by activating mammalian survival pathways (10, 61, 62). However, the possible anti-apoptotic effect of parasite MIFs on these parasites is yet to be examined.
We found that both TvMIF and huMIF confer cell survival, which may be the result of host-parasite co-evolution. This notion is supported by our previous studies showing that TvMIF and huMIF induce the same signaling pathways in human cells, conferring an anti-apoptotic and increased-growth phenotype (17), as well as by the data reported here indicating that addition of rhuMIF induces parasite survival under conditions of serum starvation. The latter observation implies that secreted huMIF could also directly affect parasite survival under adverse conditions during infection.
TvMIF was originally identified in the T. vaginalis exosomal proteome (31). HuMIF is also present in the exosomal proteome derived from a variety of human cell types (63–71). The effect of huMIF on cell survival has been shown to be mostly focused on soluble huMIF (14, 72, 73). However, Costa-Silva et al. showed that pancreatic ductal adenocarcinoma-derived exosomes with abundant huMIF play a role in inducing liver metastasis, although they did not test whether exosomal huMIF directly triggers anti-apoptotic pathways (71). Further analyses will be required to determine whether exosomal huMIF or TvMIF is capable of triggering anti-apoptotic pathways when exosomes fuse and deliver their protein cargo into human and/or trichomonad cells. Likewise, future transcriptomic and/or proteomic analyses should assist in identifying the anti-apoptotic pathway(s) triggered by TvMIF.
MATERIALS AND METHODS
T. vaginalis cell culture and transfection.
T. vaginalis strain B7RC2 (ATCC 50167) was cultured in Diamond’s medium supplemented with 100 U/ml penicillin and 100 µg/ml streptomycin (Thermo Fisher Scientific), 180 µM ferrous ammonium sulfate (Fisher), 28 µM sulfosalicylic acid (Fisher), and 10% horse serum (Sigma) (complete Diamond’s media) (26). TVAG_219770 (TvMIF) was overexpressed in Master-Neo-(HA [hemagglutinin])2 plasmid and transfected as previously described (17). The plasmid was maintained with 100 µg/ml of G418 (Gibco) for selection. Parasites were cultured at 37°C and passaged daily for 2 weeks or less.
Serum starvation assay.
T. vaginalis was cultured overnight in complete Diamond’s media (26). The parasites were then pelleted by centrifugation and resuspended at 106 cells/ml in the same media, with the exception that no horse serum was added (serum-free Diamond’s media), and incubated at 37°C at the time points indicated. At each time point, 500 µl of culture was taken from each sample and read on a FACS instrument. The survival rates of the parasites were determined by excluding dead cells using Zombie Red viability dye at a 1:1,000 dilution in PBS (BioLegend) and quantitated using CountBright Absolute Counting Beads (Thermo Fisher Scientific) with a BD LSRFortessa cell analyzer (see Fig. S2 in the supplemental material). The percentages of living cells at all of the time points were normalized to the level at time point 0 h, which was set as 100%.
Density stress assay.
EV and TvMIF-OE parasites were grown to mid-log phase (106 cells/ml) overnight and concentrated to 107 cells/ml or 2 × 107 cells/ml in complete Diamond’s media. These parasites were then incubated for 4 h or 8 h. The cells were subjected to FACS analyses using a BD LSRFortessa cell analyzer. The percentages of dead cells were determined by gating the Zombie Red-positive population and determining its percentage relative to the total cell population.
Growth assay.
EV and TvMIF-OE parasites (4 × 104 cells/ml) were cultured in complete Diamond’s media. At 12 h and 24 h, 500 µl of each sample was taken for FACS analyses to determine the numbers of living cells. Numbers of living cells were determined as described for the serum starvation assay.
Secretion assay.
The parasites were grown to mid-log phase overnight in complete Diamond’s media, collected, and resuspended in PBS–5% sucrose at 106 cells/ml. The parasites (5 × 108) were incubated at either 16°C or 37°C for 2 h. The 16°C condition was used for the secretion inhibition control. After the incubation, the parasites were spun at 3,200 rpm for 10 min and the cell pellets were collected and lysed in lysis buffer containing 50 mM Tris-HCl (pH 7.5), 2% SDS, and 1× Halt protease inhibitor cocktail (Thermo Fisher Scientific) to make whole-cell lysates (Wcl). The supernatant was passed through a PES Vivaflow crossflow cassette (Sartorious) (MWCO, 100 kDa) to separate the exosomes (Exo) from the non-exosomal soluble fraction (NESF). The NESF was concentrated by using Amicon Ultra Centrifugal filters (EMD Millipore) (MWCO, 10 K). The Exo were pelleted at 100,000 × g for 70 min. Anti-neomycin phosphotransferase (Neo) (Jackson Laboratory) (1:2,500) and anti-TvMIF antibodies (polyclonal rabbit antisera raised against TvMIF) (1:500) (4) were used as the primary antibodies and anti-rabbit antibody (Jackson Laboratory) (1:25,000) was used as the secondary antibody for both Neo and TvMIF probing.
Intracellular and secreted TvMIF quantitation.
Anti-TvMIF polyclonal antibody, anti-glyceraldehyde 3-phosphate dehydrogenase (anti-GAPDH) antibody (Cocalico Biologicals) (1:10,000), and anti-Neo antibody (Jackson Laboratory) (1:2,500) were used as the primary antibodies, and anti-rabbit (Jackson Laboratory) was used as the secondary antibody. For intracellular TvMIF quantitation, mid-log-phase parasites were spun down and washed with PBS–5% sucrose–1× Halt protease inhibitor cocktail (Thermo Fisher Scientific). The cells were then lysed in 50 mM Tris-HCl (pH 7.5)–2% SDS–1× Halt protease inhibitor cocktail lysis buffer. Equal total proteins were loaded from whole-cell lysates from 0 h, 16 h, and 24 h. For secreted TvMIF quantitation, T. vaginalis parasites cultured overnight in complete Diamond’s media were collected and resuspended in serum-free or complete Diamond’s media for 3 h or 6 h of incubation. After the incubation, the parasites were resuspended in PBS–5% sucrose for 2 h of incubation for secretion collection. The cells were spun down and collected using the method described for intracellular TvMIF quantitation as the whole-cell lysate (Wcl) control. The supernatant was then concentrated with Amicon Ultra Centrifugal Filters (MWCO = 10 K). Equal total protein amounts were loaded for the Wcl control and secreted fractions for all samples.
Production and purification of rTvMIF and rhuMIF.
TvMIF and huMIF was cloned into the pET SUMO expression vector with an N-terminal SUMO domain with 6×His tag separately. Both constructs were transformed into BL21(DE3) E. coli (Thermo Fisher Scientific) for protein expression (74). rTvMIF and rhuMIF were purified using a HisPur nickel-nitrilotriacetic acid (Ni-NTA) Spin column (Thermo Fisher Scientific) and dialyzed into 20 mM Tris-HCl (pH 8.0)–150 mM NaCl–1 mM dithiothreitol (DTT). His-tagged SUMO protease (mclab) in combination with SUMO protease buffer (50 mM Tris (pH 8.0), 1 mM DTT) was used to cleave off N-terminal SUMO and the 6×His tag to produce rTvMIF and rhuMIF with their native sequences. SUMO protease and the SUMO domain with the His tag were removed by the use of a HisPur Ni-NTA Spin column. rTvMIF and rhuMIF were then purified by the use of Econo-Pac 10DG desalting prepacked gravity flow columns (Bio-Rad).
Exogenous rTvMIF and rhuMIF addition and survival assay.
A 50 ng/ml volume of rTvMIF or rhuMIF or PBS vehicle control was added to TvMIF-OE grown in serum-free Diamond’s media. The survival rates were determined 4 h and 8 h after starvation. rTvMIF (100 ng/ml) or PBS vehicle was added to TvMIF KO parasites in serum-free Diamond’s media. The survival rates were determined 24 h after starvation.
Co-culture in transwell.
Transwell (Corning) with a 0.4-µm-pore-size polycarbonate membrane insert was used. EV or TvMIF-OE (1.8 × 105) was plated in 300 µl of complete Diamond’s media in each individual top insert, and EV (2 × 105) was plated in 1 ml of media in each individual bottom well. The top and bottom cells were passaged and rediluted daily to the concentrations described above in complete Diamond’s media. Every 7 days, the cells were resuspended in serum-free Diamond’s media at the concentration described above and incubated for 24 h for survival tests. The survival rates were determined as described for the serum starvation assays.
Apoptosis assays.
Zombie Red (1:1,000) and 4.5 µg/ml of fluorescein isothiocyanate (FITC)-annexin V (BioLegend) in annexin V binding buffer (BioLegend) were used to stain parasites grown without serum at 0 h, 16 h, and 24 h, and the cells were subjected to FACS analysis using a BD LSRFortessa cell analyzer. The live parasites were gated by excluding positive Zombie Red signal. Apoptotic levels were determined by analysis of the mean fluorescence intensity (MFI) of annexin V of live parasites. Parasites treated with dimethyl sulfoxide (DMSO) were used as the healthy control, and parasites treated with 4 µM staurosporine (STS) for 16 h composed the apoptotic control.
DNA fragmentation was done by incubating EV and TvMIF-OE in serum-free Diamond’s media and fixing parasites in 4% formaldehyde–PBS. Parasite nuclei were stained with ProLong Gold antifade mountant with 4′,6-diamidino-2-pheylindole (DAPI) (Thermo Fisher Scientific). The slides were then imaged using an Axioskop 2 epifluorescence microscope (Zeiss). The percentage of fragmented DNA was determined by the number of fragmented DNA in a total of 300 nuclei counted in each sample by using ZEN lite software.
Reactive oxygen species (ROS) detection and superoxide dismutase (SOD) mimetic treatment.
EV and TvMIF-OE parasites were grown in serum-free Diamond’s media as previously described. At 0 h, 16 h, and 24 h, cells were stained with 2 µM dihydroethidium (DHE) (Thermo Fisher Scientific) mixed with PBS at 37°C for 30 min in the dark. The MFI of ROS signal was determined by the MFI of phycoerythrin-Texas Red (PE-Texas Red)-treated live cells gated by the use of a flow cytometer.
For SOD mimetic treatment, a 250 µM or 500 µM concentration of manganese(III) tetrakis(1-methyl-4-pyridyl)porphyrin (MnTmPyP) (Sigma) or DMSO was used to treat parasites grown in serum-free Diamond’s media at time point 0 h. At 16 h, parasites were stained with DHE and CountBright absolute counting beads (Thermo Fisher Scientific) were added to determine the number of live cells. The ROS signal and the percentage of living cells were measured by the use of a flow cytometer.
Gene knockout and adding back of TvMIF in T. vaginalis B7RC2.
The constructs and reagents used to create the TvMIF knockout were as described by Janssen et al. (4). Adding back of TvMIF to TvMIF KO cells was done by transfection of TVAG_219770 (TvMIF) in Master-Neo-(HA)2 plasmid with selection of G418 at the concentration of 900 µg/ml in order to select for the plasmid in the presence of a neomycin phosphotransferase (Neo) gene knock-in at the TvMIF gene locus, replacing the TvMIF gene.
ACKNOWLEDGMENTS
We thank Natalia de Miguel and Feng Guo for providing the TvMIF antibody and the pET SUMO plasmid, respectively. We thank members of the Johnson laboratory for intellectual discussion and David Campbell, Azeez Aranmolate, Brian Janssen and Frances Mercer, and Brenda Molgora for helpful comments on the manuscript.
This work was supported by NIH grants R01 AI103182 and R21 AI105779 (P.J.J.) and NIH grant T32 AI007323 (Y.-P.C.).
Y.-P.C. and P.J.J. designed the research; Y.-P.C. and O.T. performed the research; Y.-P.C. and P.J.J. analyzed the data; and Y.-P.C. and P.J.J. wrote the paper.
Footnotes
Citation Chen Y-P, Twu O, Johnson PJ. 2018. Trichomonas vaginalis macrophage migration inhibitory factor mediates parasite survival during nutrient stress. mBio 9:e00910-18. https://doi.org/10.1128/mBio.00910-18.
REFERENCES
- 1.World Health Organization 2008. Global incidence and prevalence of selected curable sexually transmitted infections. World Health Organization, Geneva, Switzerland. [Google Scholar]
- 2.Secor WE, Meites E, Starr MC, Workowski KA. 2014. Neglected parasitic infections in the United States: trichomoniasis. Am J Trop Med Hyg 90:800–804. doi: 10.4269/ajtmh.13-0723. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Conrad MD, Bradic M, Warring SD, Gorman AW, Carlton JM. 2013. Getting Trichy: tools and approaches to interrogating Trichomonas vaginalis in a post-genome world. Trends Parasitol 29:17–25. doi: 10.1016/j.pt.2012.10.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Janssen BD, Chen YP, Molgora BM, Wang SE, Simoes-Barbosa A, Johnson PJ. 2018. CRISPR/Cas9-mediated gene modification and gene knock out in the human-infective parasite Trichomonas vaginalis. Sci Rep 8:270. doi: 10.1038/s41598-017-18442-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Petrin D, Delgaty K, Bhatt R, Garber G. 1998. Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev 11:300–317. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.McClelland RS, Sangare L, Hassan WM, Lavreys L, Mandaliya K, Kiarie J, Ndinya-Achola J, Jaoko W, Baeten JM. 2007. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 195:698–702. doi: 10.1086/511278. [DOI] [PubMed] [Google Scholar]
- 7.Ryan CM, de Miguel N, Johnson PJ. 2011. Trichomonas vaginalis: current understanding of host-parasite interactions. Essays Biochem 51:161–175. doi: 10.1042/bse0510161. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Hirt RP. 2013. Trichomonas vaginalis virulence factors: an integrative overview. Sex Transm Infect 89:439–443. doi: 10.1136/sextrans-2013-051105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Leitsch D. 2016. Recent advances in the Trichomonas vaginalis field. F1000Res 5:162. doi: 10.12688/f1000research.7594.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Kamir D, Zierow S, Leng L, Cho Y, Diaz Y, Griffith J, McDonald C, Merk M, Mitchell RA, Trent J, Chen Y, Kwong YK, Xiong H, Vermeire J, Cappello M, McMahon-Pratt D, Walker J, Bernhagen J, Lolis E, Bucala R. 2008. A Leishmania ortholog of macrophage migration inhibitory factor modulates host macrophage responses. J Immunol 180:8250–8261. doi: 10.4049/jimmunol.180.12.8250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Wasala NB, Jaworski DC. 2012. Dermacentor variabilis: characterization and modeling of macrophage migration inhibitory factor with phylogenetic comparisons to other ticks, insects and parasitic nematodes. Exp Parasitol 130:232–238. doi: 10.1016/j.exppara.2011.12.010. [DOI] [PubMed] [Google Scholar]
- 12.Panstruga R, Baumgarten K, Bernhagen J. 2015. Phylogeny and evolution of plant macrophage migration inhibitory factor/D-dopachrome tautomerase-like proteins. BMC Evol Biol 15:64. doi: 10.1186/s12862-015-0337-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Sparkes A, De Baetselier P, Roelants K, De Trez C, Magez S, Van Ginderachter JA, Raes G, Bucala R, Stijlemans B. 2017. The non-mammalian MIF superfamily. Immunobiology 222:473–482. doi: 10.1016/j.imbio.2016.10.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Calandra T, Roger T. 2003. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3:791–800. doi: 10.1038/nri1200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Lue H, Thiele M, Franz J, Dahl E, Speckgens S, Leng L, Fingerle-Rowson G, Bucala R, Lüscher B, Bernhagen J. 2007. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene 26:5046–5059. doi: 10.1038/sj.onc.1210318. [DOI] [PubMed] [Google Scholar]
- 16.Lue H, Kleemann R, Calandra T, Roger T, Bernhagen J. 2002. Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect 4:449–460. doi: 10.1016/S1286-4579(02)01560-5. [DOI] [PubMed] [Google Scholar]
- 17.Twu O, Dessí D, Vu A, Mercer F, Stevens GC, de Miguel N, Rappelli P, Cocco AR, Clubb RT, Fiori PL, Johnson PJ. 2014. Trichomonas vaginalis homolog of macrophage migration inhibitory factor induces prostate cell growth, invasiveness, and inflammatory responses. Proc Natl Acad Sci U S A 111:8179–8184. doi: 10.1073/pnas.1321884111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Augustijn KD, Kleemann R, Thompson J, Kooistra T, Crawford CE, Reece SE, Pain A, Siebum AH, Janse CJ, Waters AP. 2007. Functional characterization of the Plasmodium falciparum and P. berghei homologues of macrophage migration inhibitory factor. Infect Immun 75:1116–1128. doi: 10.1128/IAI.00902-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Cho Y, Jones BF, Vermeire JJ, Leng L, DiFedele L, Harrison LM, Xiong H, Kwong YK, Chen Y, Bucala R, Lolis E, Cappello M. 2007. Structural and functional characterization of a secreted hookworm macrophage migration inhibitory factor (MIF) that interacts with the human MIF receptor CD74. J Biol Chem 282:23447–23456. doi: 10.1074/jbc.M702950200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Sommerville C, Richardson JM, Williams RA, Mottram JC, Roberts CW, Alexander J, Henriquez FL. 2013. Biochemical and immunological characterization of Toxoplasma gondii macrophage migration inhibitory factor. J Biol Chem 288:12733–12741. doi: 10.1074/jbc.M112.419911. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Tan TH, Edgerton SA, Kumari R, McAlister MS, Roe SM, Nagl S, Pearl LH, Selkirk ME, Bianco AE, Totty NF, Engwerda C, Gray CA, Meyer DJ. 2001. Macrophage migration inhibitory factor of the parasitic nematode Trichinella spiralis. Biochem J 357:373–383. doi: 10.1042/bj3570373. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Deponte M. 2008. Programmed cell death in protists. Biochim Biophys Acta 1783:1396–1405. doi: 10.1016/j.bbamcr.2008.01.018. [DOI] [PubMed] [Google Scholar]
- 23.Kaczanowski S, Sajid M, Reece SE. 2011. Evolution of apoptosis-like programmed cell death in unicellular protozoan parasites. Parasit Vectors 4:44. doi: 10.1186/1756-3305-4-44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Chose O, Noël C, Gerbod D, Brenner C, Viscogliosi E, Roseto A. 2002. A form of cell death with some features resembling apoptosis in the amitochondrial unicellular organism Trichomonas vaginalis. Exp Cell Res 276:32–39. doi: 10.1006/excr.2002.5496. [DOI] [PubMed] [Google Scholar]
- 25.Ofer K, Gold D, Flescher E. 2008. Methyl jasmonate induces cell cycle block and cell death in the amitochondriate parasite Trichomonas vaginalis. Int J Parasitol 38:959–968. doi: 10.1016/j.ijpara.2007.12.008. [DOI] [PubMed] [Google Scholar]
- 26.Clark CG, Diamond LS. 2002. Methods for cultivation of luminal parasitic protists of clinical importance. Clin Microbiol Rev 15:329–341. doi: 10.1128/CMR.15.3.329-341.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Gelbart SM, Thomason JL, Osypowski PJ, Kellett AV, James JA, Broekhuizen FF. 1990. Growth of Trichomonas vaginalis in commercial culture media. J Clin Microbiol 28:962–964. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Delgadillo MG, Liston DR, Niazi K, Johnson PJ. 1997. Transient and selectable transformation of the parasitic protist Trichomonas vaginalis. Proc Natl Acad Sci U S A 94:4716–4720. doi: 10.1073/pnas.94.9.4716. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Twu O, Johnson PJ. 2014. Parasite extracellular vesicles: mediators of intercellular communication. PLoS Pathog 10:e1004289. doi: 10.1371/journal.ppat.1004289. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Marti M, Johnson PJ. 2016. Emerging roles for extracellular vesicles in parasitic infections. Curr Opin Microbiol 32:66–70. doi: 10.1016/j.mib.2016.04.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Twu O, de Miguel N, Lustig G, Stevens GC, Vashisht AA, Wohlschlegel JA, Johnson PJ. 2013. Trichomonas vaginalis exosomes deliver cargo to host cells and mediate host-parasite interactions. PLoS Pathog 9:e1003482. doi: 10.1371/journal.ppat.1003482. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Flieger O, Engling A, Bucala R, Lue H, Nickel W, Bernhagen J. 2003. Regulated secretion of macrophage migration inhibitory factor is mediated by a non-classical pathway involving an ABC transporter. FEBS Lett 551:78–86. doi: 10.1016/S0014-5793(03)00900-1. [DOI] [PubMed] [Google Scholar]
- 33.Mitchell RA, Metz CN, Peng T, Bucala R. 1999. Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action. J Biol Chem 274:18100–18106. doi: 10.1074/jbc.274.25.18100. [DOI] [PubMed] [Google Scholar]
- 34.Du W, Wright BM, Li X, Finke J, Rini BI, Zhou M, He H, Lal P, Welford SM. 2013. Tumor-derived macrophage migration inhibitory factor promotes an autocrine loop that enhances renal cell carcinoma. Oncogene 32:1469–1474. doi: 10.1038/onc.2012.143. [DOI] [PubMed] [Google Scholar]
- 35.Bozza MT, Martins YC, Carneiro LAM, Paiva CN. 2012. Macrophage migration inhibitory factor in protozoan infections. J Parasitol Res 2012:413052. doi: 10.1155/2012/413052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Rosado JDD, Rodriguez-Sosa M. 2011. Macrophage migration inhibitory factor (MIF): a key player in protozoan infections. Int J Biol Sci 7:1239–1256. doi: 10.7150/ijbs.7.1239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ, Beach DH. 1999. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 190:1375–1382. doi: 10.1084/jem.190.10.1375. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J, Bucala R. 2002. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci U S A 99:345–350. doi: 10.1073/pnas.012511599. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Mitchell RA, Bucala R. 2000. Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF). Semin Cancer Biol 10:359–366. doi: 10.1006/scbi.2000.0328. [DOI] [PubMed] [Google Scholar]
- 40.Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. 1995. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 184:39–51. doi: 10.1016/0022-1759(95)00072-I. [DOI] [PubMed] [Google Scholar]
- 41.Simon HU, Haj-Yehia A, Levi-Schaffer F. 2000. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5:415–418. doi: 10.1023/A:1009616228304. [DOI] [PubMed] [Google Scholar]
- 42.Koga K, Kenessey A, Ojamaa K. 2013. Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy. Am J Physiol Heart Circ Physiol 304:H282–H293. doi: 10.1152/ajpheart.00595.2012. [DOI] [PubMed] [Google Scholar]
- 43.Sobierajski J, Hendgen-Cotta U, Lüdike P, Rammos C, Bernhagen J, Kelm M, Rassaf T. 2013. Time dependent regulation of MIF by S-nitros(yl)ation reduces apoptosis in myocardial I/R-injury. Eur Heart J 34:P4990. doi: 10.1093/eurheartj/eht310.P4990. [DOI] [Google Scholar]
- 44.Zhao H, Joseph J, Fales HM, Sokoloski EA, Levine RL, Vasquez-Vivar J, Kalyanaraman B. 2005. Detection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fluorescence. Proc Natl Acad Sci U S A 102:5727–5732. doi: 10.1073/pnas.0501719102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Nguyen MT, Lue H, Kleemann R, Thiele M, Tolle G, Finkelmeier D, Wagner E, Braun A, Bernhagen J. 2003. The cytokine macrophage migration inhibitory factor reduces pro-oxidative stress-induced apoptosis. J Immunol 170:3337–3347. doi: 10.4049/jimmunol.170.6.3337. [DOI] [PubMed] [Google Scholar]
- 46.Wilson JM, Coletta PL, Cuthbert RJ, Scott N, MacLennan K, Hawcroft G, Leng L, Lubetsky JB, Jin KK, Lolis E, Medina F, Brieva JA, Poulsom R, Markham AF, Bucala R, Hull MA. 2005. Macrophage migration inhibitory factor promotes intestinal tumorigenesis. Gastroenterology 129:1485–1503. doi: 10.1053/j.gastro.2005.07.061. [DOI] [PubMed] [Google Scholar]
- 47.Conroy H, Mawhinney L, Donnelly SC. 2010. Inflammation and cancer: macrophage migration inhibitory factor (MIF)—the potential missing link. QJM 103:831–836. doi: 10.1093/qjmed/hcq148. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Denz A, Pilarsky C, Muth D, Rückert F, Saeger HD, Grützmann R. 2010. Inhibition of MIF leads to cell cycle arrest and apoptosis in pancreatic cancer cells. J Surg Res 160:29–34. doi: 10.1016/j.jss.2009.03.048. [DOI] [PubMed] [Google Scholar]
- 49.Cheng WH, Huang KY, Huang PJ, Hsu JH, Fang YK, Chiu CH, Tang P. 2015. Nitric oxide maintains cell survival of Trichomonas vaginalis upon iron depletion. Parasit Vectors 8:393. doi: 10.1186/s13071-015-1000-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Huang KY, Chen YY, Fang YK, Cheng WH, Cheng CC, Chen YC, Wu TE, Ku FM, Chen SC, Lin R, Tang P. 2014. Adaptive responses to glucose restriction enhance cell survival, antioxidant capability, and autophagy of the protozoan parasite Trichomonas vaginalis. Biochim Biophys Acta 1840:53–64. doi: 10.1016/j.bbagen.2013.08.008. [DOI] [PubMed] [Google Scholar]
- 51.Frasson AP, Charão MF, Rosemberg DB, de Souza AP, Garcia SC, Bonorino C, Bogo MR, De Carli GA, Tasca T. 2012. Analysis of the NTPDase and ecto-5′-nucleotidase profiles in serum-limited Trichomonas vaginalis. Mem Inst Oswaldo Cruz 107:170–177. doi: 10.1590/S0074-02762012000200004. [DOI] [PubMed] [Google Scholar]
- 52.Mukherjee SB, Das M, Sudhandiran G, Shaha C. 2002. Increase in cytosolic Ca2+ levels through the activation of non-selective cation channels induced by oxidative stress causes mitochondrial depolarization leading to apoptosis-like death in Leishmania donovani promastigotes. J Biol Chem 277:24717–24727. doi: 10.1074/jbc.M201961200. [DOI] [PubMed] [Google Scholar]
- 53.Sen N, Das BB, Ganguly A, Mukherjee T, Tripathi G, Bandyopadhyay S, Rakshit S, Sen T, Majumder HK. 2004. Camptothecin induced mitochondrial dysfunction leading to programmed cell death in unicellular hemoflagellate Leishmania donovani. Cell Death Differ 11:924–936. doi: 10.1038/sj.cdd.4401435. [DOI] [PubMed] [Google Scholar]
- 54.Sen N, Das BB, Ganguly A, Mukherjee T, Bandyopadhyay S, Majumder HK. 2004. Camptothecin-induced imbalance in intracellular cation homeostasis regulates programmed cell death in unicellular hemoflagellate Leishmania donovani. J Biol Chem 279:52366–52375. doi: 10.1074/jbc.M406705200. [DOI] [PubMed] [Google Scholar]
- 55.Alzate JF, Arias AA, Moreno-Mateos D, Alvarez-Barrientos A, Jiménez-Ruiz A. 2007. Mitochondrial superoxide mediates heat-induced apoptotic-like death in Leishmania infantum. Mol Biochem Parasitol 152:192–202. doi: 10.1016/j.molbiopara.2007.01.006. [DOI] [PubMed] [Google Scholar]
- 56.Piacenza L, Irigoín F, Alvarez MN, Peluffo G, Taylor MC, Kelly JM, Wilkinson SR, Radi R. 2007. Mitochondrial superoxide radicals mediate programmed cell death in Trypanosoma cruzi: cytoprotective action of mitochondrial iron superoxide dismutase overexpression. Biochem J 403:323–334. doi: 10.1042/BJ20061281. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Figarella K, Uzcategui NL, Beck A, Schoenfeld C, Kubata BK, Lang F, Duszenko M. 2006. Prostaglandin-induced programmed cell death in Trypanosoma brucei involves oxidative stress. Cell Death Differ 13:1802–1814. doi: 10.1038/sj.cdd.4401862. [DOI] [PubMed] [Google Scholar]
- 58.Suzuki M, Takamura Y, Maéno M, Tochinai S, Iyaguchi D, Tanaka I, Nishihira J, Ishibashi T. 2004. Xenopus laevis macrophage migration inhibitory factor is essential for axis formation and neural development. J Biol Chem 279:21406–21414. doi: 10.1074/jbc.M311416200. [DOI] [PubMed] [Google Scholar]
- 59.Marson AL, Tarr DE, Scott AL. 2001. Macrophage migration inhibitory factor (mif) transcription is significantly elevated in Caenorhabditis elegans dauer larvae. Gene 278:53–62. doi: 10.1016/S0378-1119(01)00706-5. [DOI] [PubMed] [Google Scholar]
- 60.Moonah SN, Abhyankar MM, Haque R, Petri WA Jr.. 2014. The macrophage migration inhibitory factor homolog of Entamoeba histolytica binds to and immunomodulates host macrophages. Infect Immun 82:3523–3530. doi: 10.1128/IAI.01812-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Shao D, Zhong X, Zhou YF, Han Z, Lin Y, Wang Z, Bu L, Zhang L, Su XD, Wang H. 2010. Structural and functional comparison of MIF ortholog from Plasmodium yoelii with MIF from its rodent host. Mol Immunol 47:726–737. doi: 10.1016/j.molimm.2009.10.037. [DOI] [PubMed] [Google Scholar]
- 62.Holowka T, Castilho TM, Garcia AB, Sun T, McMahon-Pratt D, Bucala R. 2016. Leishmania-encoded orthologs of macrophage migration inhibitory factor regulate host immunity to promote parasite persistence. FASEB J 30:2249–2265. doi: 10.1096/fj.201500189R. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Buschow SI, van Balkom BW, Aalberts M, Heck AJ, Wauben M, Stoorvogel W. 2010. MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis. Immunol Cell Biol 88:851–856. doi: 10.1038/icb.2010.64. [DOI] [PubMed] [Google Scholar]
- 64.Welton JL, Khanna S, Giles PJ, Brennan P, Brewis IA, Staffurth J, Mason MD, Clayton A. 2010. Proteomics analysis of bladder cancer exosomes. Mol Cell Proteomics 9:1324–1338. doi: 10.1074/mcp.M000063-MCP201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Admyre C, Johansson SM, Qazi KR, Filén JJ, Lahesmaa R, Norman M, Neve EP, Scheynius A, Gabrielsson S. 2007. Exosomes with immune modulatory features are present in human breast milk. J Immunol 179:1969–1978. doi: 10.4049/jimmunol.179.3.1969. [DOI] [PubMed] [Google Scholar]
- 66.Choi DS, Lee JM, Park GW, Lim HW, Bang JY, Kim YK, Kwon KH, Kwon HJ, Kim KP, Gho YS. 2007. Proteomic analysis of microvesicles derived from human colorectal cancer cells. J Proteome Res 6:4646–4655. doi: 10.1021/pr070192y. [DOI] [PubMed] [Google Scholar]
- 67.He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N. 2015. Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs. Carcinogenesis 36:1008–1018. doi: 10.1093/carcin/bgv081. [DOI] [PubMed] [Google Scholar]
- 68.Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S, Burlet-Schiltz O, Larue L, Muller C, Nieto L. 2015. Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines. Pigment Cell Melanoma Res 28:464–475. doi: 10.1111/pcmr.12380. [DOI] [PubMed] [Google Scholar]
- 69.Hosseini-Beheshti E, Pham S, Adomat H, Li N, Tomlinson Guns ES. 2012. Exosomes as biomarker enriched microvesicles: characterization of exosomal proteins derived from a panel of prostate cell lines with distinct AR phenotypes. Mol Cell Proteomics 11:863–885. doi: 10.1074/mcp.M111.014845. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Park JE, Tan HS, Datta A, Lai RC, Zhang H, Meng W, Lim SK, Sze SK. 2010. Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol Cell Proteomics 9:1085–1099. doi: 10.1074/mcp.M900381-MCP200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H, Xiang J, Zhang T, Theilen TM, García-Santos G, Williams C, Ararso Y, Huang Y, Rodrigues G, Shen TL, Labori KJ, Lothe IM, Kure EH, Hernandez J, Doussot A, Ebbesen SH, Grandgenett PM, Hollingsworth MA, Jain M, Mallya K, Batra SK, Jarnagin WR, Schwartz RE, Matei I, Peinado H, Stanger BZ, Bromberg J, Lyden D. 2015. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol 17:816–826. doi: 10.1038/ncb3169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Donn RP, Ray DW. 2004. Macrophage migration inhibitory factor: molecular, cellular and genetic aspects of a key neuroendocrine molecule. J Endocrinol 182:1–9. doi: 10.1677/joe.0.1820001. [DOI] [PubMed] [Google Scholar]
- 73.Fingerle-Rowson GR, Bucala R. 2001. Neuroendocrine properties of macrophage migration inhibitory factor (MIF). Immunol Cell Biol 79:368–375. doi: 10.1046/j.1440-1711.2001.01024.x. [DOI] [PubMed] [Google Scholar]
- 74.Malakhov MP, Mattern MR, Malakhova OA, Drinker M, Weeks SD, Butt TR. 2004. SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins. J Struct Funct Genomics 5:75–86. doi: 10.1023/B:JSFG.0000029237.70316.52. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.